Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796744 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
A Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic, sponsored by US Biotest.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
- 12
- Study locations
NCT00796744 is a Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic that has completed, run by US Biotest. The registered enrollment target is 78 participants, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The trial reports 12 study locations across 9 states.
The verdict
NCT00796744, a Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic, has completed, sponsored by US Biotest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to assess if the experimental drug, DSC127, is safe, how well it can be tolerated, and how different doses effect the healing of the chronic foot ulcers in diabetic subjects.
Conditions Studied
Interventions
- DRUG NorLeu3-A(1-7) in a gel formulation
Study Locations (12)
California
- Bay Area Footcare - Castro Valley
- University of California, San Diego - San Diego
- Olive View - UCLA Medical Center - Sylmar
Arizona
- Southern Arizona VA Health Care System - Tucson
- Southern Arizona Limb Salvage Alliance (SALSA) - Tucson
Illinois
- Passavant Area Hospital - Jacksonville
Maryland
- Georgetown University Medical Center - Georgetown
Massachusetts
- Boston University School of Medicine - Boston
North Carolina
- Eastern Carolina Foot & Ankle Specialists - Greenville
Pennsylvania
- Warren General Hospital Wound Clinic - Warren
Texas
- Renaissance Hospital Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00796744
The ClinicalTrials.gov registry entry for NCT00796744 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The listed sponsor is US Biotest, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 1 intervention - of which NorLeu3-A(1-7) in a gel formulation is the first listed.
NCT00796744 reports 12 study locations spanning 9 distinct geographic areas - top geographies include California, Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT00796744 about?
NCT00796744 is a clinical study titled "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers". The purpose of this study is to assess if the experimental drug, DSC127, is safe, how well it can be tolerated, and how different doses effect the healing of the chronic foot ulcers in diabetic subjects.
What is the current status of trial NCT00796744?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2008-10. Estimated completion is 2011-05.
What conditions does trial NCT00796744 study?
This clinical trial studies the following conditions: Diabetic Foot, Foot Ulcer, Diabetic.
What interventions are being tested in trial NCT00796744?
The interventions under investigation include: NorLeu3-A(1-7) in a gel formulation (DRUG).
Who is sponsoring clinical trial NCT00796744?
This trial is sponsored by US Biotest, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00796744 being conducted?
This trial has 12 study locations across Arizona, California, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
COMPLETED · Phase 2
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.